DWTX Dogwood Therapeutics, Inc.
Fundamentals / CIK 0001818844 / USDDogwood Therapeutics, Inc. reported $75.61M in total assets and a net loss of $25.18M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DWTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$27.86M Operating profit
-
Net Income FY 2025-$25.18M GAAP bottom line
-
Diluted EPS FY 2025-$0.74 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$4.95M Total debt: $118K
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $21.87M | $3.53M | $1.73M | $8.07M | $10.80M | $194K |
| Total Operating Expenses | $27.97M | $12.23M | $5.45M | $12.32M | $15.64M | $10.01M |
| Operating Income | -$27.97M | -$12.23M | -$5.45M | -$12.32M | -$15.64M | -$10.01M |
| EBITDA | -$27.97M | -$12.22M | -- | -- | -- | -- |
| Income Before Tax | -$34.04M | -$12.35M | -$5.30M | -$12.25M | -$15.96M | -$10.35M |
| Income Tax Expense | $221K | -$503 | -- | -- | -- | -- |
| Net Income | -$34.26M | -$12.35M | -$5.30M | -$12.25M | -$15.96M | -$10.35M |
| Basic EPS | -$7.13 | -$12.52 | -$0.28 | -$1.11 | -$1.92 | -$2.10 |
| Diluted EPS | -$7.13 | -$12.52 | -$0.28 | -$1.11 | -$1.92 | -$2.10 |
| Basic Shares Outstanding | 5.0M | 1.0M | 18.8M | 11.1M | 8.3M | 4.9M |
| Diluted Shares Outstanding | 5.0M | 1.0M | 18.8M | 11.1M | 8.3M | 4.9M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100K | -- | -- | -- | -- | -- | -- | -- |
| Cost of Revenue | $88K | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | $12K | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $3.35M | $3.25M | $2.67M | $2.34M | $14.52M | $2.57M | $2.44M | $2.32M |
| Total Operating Expenses | $4.93M | $14.06M | $5.08M | $3.81M | $15.81M | $3.92M | $4.43M | $7.54M |
| Operating Income | -$4.92M | -$14.06M | -$5.08M | -$3.81M | -$15.81M | -$3.92M | -$4.43M | -$7.54M |
| EBITDA | -- | -- | -- | -$3.81M | -$15.84M | -$3.91M | -$4.41M | -- |
| Income Before Tax | -$4.88M | -$14.01M | -$4.99M | -$3.75M | -$15.75M | -$3.81M | -$10.73M | -$7.73M |
| Net Income | -$4.88M | -$11.53M | -$4.99M | -$3.78M | -$15.74M | -$3.81M | -$10.92M | -$7.73M |
| Basic EPS | -$0.14 | -$0.34 | -$0.15 | -- | -$8.20 | -$1.99 | -$8.45 | -- |
| Diluted EPS | -$0.14 | -$0.34 | -$0.15 | -- | -$8.20 | -$1.99 | -$8.45 | -- |
| Basic Shares Outstanding | 34.1M | 34.1M | 33.5M | -- | 1.9M | 1.9M | 1.4M | -- |
| Diluted Shares Outstanding | 34.1M | 34.1M | 33.5M | -- | 1.9M | 1.9M | 1.4M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $6.52M | $14.85M | $3.32M | $7.03M | $14.01M | $29.80M |
| Cash & Short-Term Investments | $6.52M | $14.85M | $3.32M | $7.03M | $14.01M | $29.80M |
| Total Current Assets | $8.43M | $16.54M | $4.17M | $8.37M | $15.78M | $31.47M |
| Property, Plant & Equipment, Net | $13K | $17K | -- | -- | -- | -- |
| Goodwill | $12.40M | $11.81M | -- | -- | -- | -- |
| Intangible Assets | $68.99M | $65.71M | -- | -- | -- | -- |
| Total Non-Current Assets | $81.74M | $77.76M | $0 | $0 | $0 | $0 |
| Total Assets | $90.17M | $94.31M | $4.17M | $8.37M | $15.78M | $31.47M |
| Accounts Payable | $761K | $1.23M | $112K | $573K | $354K | $369K |
| Total Current Liabilities | $3.06M | $3.18M | $359K | $1.04M | $1.28M | $1.53M |
| Other Non-Current Liabilities | -- | $15.38M | -- | -- | -- | -- |
| Total Non-Current Liabilities | $12.22M | $26.85M | $0 | $0 | $0 | $0 |
| Total Liabilities | $15.27M | $30.03M | $359K | $1.04M | $1.28M | $1.53M |
| Total Debt (incl. Leases) | $163K | $205K | -- | -- | -- | -- |
| Common Stock | $3.0K | $133 | $77 | $1.8K | $833 | $830 |
| Retained Earnings | -$108.1M | -$73.82M | -$61.47M | -$56.17M | -$43.93M | -$27.97M |
| Accumulated Other Comp. Income | -$587K | -$3.86M | -- | -- | -- | -- |
| Total Stockholders' Equity | $74.90M | -$10.12M | $3.81M | $7.33M | $14.50M | $29.94M |
| Total Equity | $74.90M | -$10.12M | $3.81M | $7.33M | $14.50M | $29.94M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.95M | $9.61M | $13.23M | $6.52M | $10.13M | $13.40M | $17.54M | $14.85M |
| Cash & Short-Term Investments | $4.95M | $9.61M | $13.23M | $6.52M | $10.13M | $13.40M | $17.54M | $14.85M |
| Total Current Assets | $6.04M | $11.03M | $15.00M | $8.43M | $11.66M | $14.70M | $19.16M | $16.54M |
| Property, Plant & Equipment, Net | $12K | $12K | $13K | $13K | $15K | $16K | $16K | $17K |
| Goodwill | $11.98M | $11.96M | $12.19M | $12.40M | $12.21M | $12.46M | $11.82M | $11.81M |
| Intangible Assets | $57.44M | $57.35M | $67.83M | $68.99M | $67.92M | $69.30M | $65.77M | $65.71M |
| Total Non-Current Assets | $69.56M | $69.47M | $80.20M | $81.74M | $80.34M | $81.99M | $77.82M | $77.76M |
| Total Assets | $75.61M | $80.50M | $95.21M | $90.17M | $91.99M | $96.69M | $96.98M | $94.31M |
| Accounts Payable | $170K | $412K | $144K | $761K | $585K | $498K | $1.15M | $1.23M |
| Total Current Liabilities | $2.17M | $2.83M | $2.56M | $3.06M | $2.60M | $1.89M | $2.58M | $3.18M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $15.38M |
| Total Non-Current Liabilities | $9.30M | $9.30M | $12.02M | $12.22M | $12.01M | $12.27M | $11.66M | $26.85M |
| Total Liabilities | $11.47M | $12.13M | $14.58M | $15.27M | $14.61M | $14.15M | $14.24M | $30.03M |
| Total Debt (incl. Leases) | $118K | $127K | $145K | $163K | $175K | $187K | $191K | $205K |
| Common Stock | $3.4K | $3.4K | $3.3K | $3.0K | $229 | $191 | $191 | $133 |
| Retained Earnings | -$129.5M | -$124.6M | -$113.1M | -$108.1M | -$104.3M | -$88.55M | -$84.74M | -$73.82M |
| Accumulated Other Comp. Income | -$2.90M | -$2.99M | -$1.72M | -$587K | -$1.64M | -$267K | -$3.80M | -$3.86M |
| Total Stockholders' Equity | $64.13M | $68.37M | $80.62M | $74.90M | $7.26M | $6.88M | $7.09M | -$10.12M |
| Total Equity | $64.13M | $68.37M | $80.62M | $74.90M | $7.26M | $6.88M | $7.09M | -$10.12M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$34.26M | -$12.35M | -$5.30M | -$12.25M | -$15.96M | -$10.35M |
| Depreciation & Amortization | $2.1K | $12K | -- | -- | -- | -- |
| Stock-Based Compensation | $356K | $476K | $620K | $583K | $323K | $7.43M |
| Change in Payables | -$533K | $220K | -$461K | $219K | $270K | $52K |
| Operating Cash Flow | -$15.62M | -$8.79M | -$4.87M | -$11.47M | -$15.69M | -$3.90M |
| Investing Cash Flow | -- | $3.76M | -- | -- | -- | -- |
| Common Stock Issued | -- | -- | $1.16M | -- | -- | -- |
| Financing Cash Flow | $7.28M | $16.70M | $1.16M | $4.49M | -$98K | $33.38M |
| Net Change in Cash | -$8.33M | $11.68M | -$3.71M | -$6.98M | -$15.79M | $29.49M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.88M | -$11.53M | -$4.99M | -$3.78M | -$15.74M | -$3.81M | -$10.92M | -$7.73M |
| Depreciation & Amortization | -- | -- | -- | $0 | -$32K | $17K | $17K | -- |
| Stock-Based Compensation | $558K | $543K | $449K | $158K | $48K | $65K | $84K | $94K |
| Change in Payables | -$246K | $264K | -$590K | $119K | $87K | -$607K | -$131K | -$123K |
| Operating Cash Flow | -$4.64M | -$3.61M | -$4.59M | -$3.64M | -$3.27M | -$4.03M | -$4.68M | -$6.13M |
| Financing Cash Flow | $50 | $23 | $11.29M | $33K | $0 | -$120K | $7.37M | -- |
| Net Change in Cash | -$4.64M | -$3.61M | $6.70M | -$3.60M | -$3.27M | -$4.15M | $2.69M | $12.95M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -45.7% | -- | -139.1% | -167.2% | -110.1% | -34.6% |
| Return on Assets (ROA) | -38.0% | -13.1% | -127.1% | -146.3% | -101.2% | -32.9% |
| Current Ratio | 2.76x | 5.21x | 11.62x | 8.02x | 12.37x | 20.55x |
| Quick Ratio | 2.13x | 4.67x | 9.25x | 6.74x | 10.98x | 19.45x |
| Debt to Equity | 0.00x | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -39.3% | -52.7% | -35.1% | -45.7% | -526.4% | -359.7% | -310.2% | -- |
| Return on Assets (ROA) | -33.3% | -44.8% | -29.7% | -38.0% | -41.5% | -25.6% | -22.7% | -13.1% |
| Current Ratio | 2.78x | 3.89x | 5.86x | 2.76x | 4.49x | 7.80x | 7.43x | 5.21x |
| Quick Ratio | 2.28x | 3.39x | 5.17x | 2.13x | 3.90x | 7.11x | 6.80x | 4.67x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.02x | 0.03x | 0.03x | -- |